Annual CFF
$568.44 M
+$294.17 M+107.26%
31 December 2023
Summary:
ACELYRIN annual cash flow from financing activities is currently $568.44 million, with the most recent change of +$294.17 million (+107.26%) on 31 December 2023. SLRN annual CFF is now at all-time high.SLRN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.01 M
+$1.29 M+448.10%
30 September 2024
Summary:
ACELYRIN quarterly cash flow from financing activities is currently $1.01 million, with the most recent change of +$1.29 million (+448.10%) on 30 September 2024. Over the past year, it has increased by +$1.50 million (+301.60%). SLRN quarterly CFF is now -99.82% below its all-time high of $566.47 million, reached on 30 June 2023.SLRN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$6.12 M
+$1.50 M+32.61%
30 September 2024
Summary:
ACELYRIN TTM cash flow from financing activities is currently $6.12 million, with the most recent change of +$1.50 million (+32.61%) on 30 September 2024. Over the past year, it has dropped by -$559.37 million (-98.92%). SLRN TTM CFF is now -99.14% below its all-time high of $715.63 million, reached on 30 June 2023.SLRN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLRN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +107.3% | +301.6% | -98.9% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
SLRN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +355.8% | -99.8% | +301.6% | -99.1% | +32.6% |
| 5 y | 5 years | at high | +355.8% | -99.8% | +301.6% | -99.1% | +32.6% |
| alltime | all time | at high | +355.8% | -99.8% | +301.6% | -99.1% | +32.6% |
ACELYRIN Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.01 M(-448.1%) | $6.12 M(+32.6%) |
| June 2024 | - | -$289.00 K(-110.3%) | $4.62 M(-99.2%) |
| Mar 2024 | - | $2.81 M(+8.1%) | $571.37 M(+0.5%) |
| Dec 2023 | $568.44 M | $2.60 M(-620.2%) | $568.44 M(+0.5%) |
| Sept 2023 | - | -$499.00 K(-100.1%) | $565.49 M(-21.0%) |
| June 2023 | - | $566.47 M(<-9900.0%) | $715.63 M(+379.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$129.00 K(-63.2%) | $149.16 M(-45.6%) |
| Dec 2022 | $274.26 M(+119.9%) | -$351.00 K(-100.2%) | $274.26 M(-0.1%) |
| Sept 2022 | - | $149.64 M(>+9900.0%) | $274.61 M(+119.7%) |
| June 2022 | - | $0.00(-100.0%) | $124.97 M(0.0%) |
| Mar 2022 | - | $124.97 M | $124.97 M |
| Dec 2021 | $124.72 M | - | - |
FAQ
- What is ACELYRIN annual cash flow from financing activities?
- What is the all time high annual CFF for ACELYRIN?
- What is ACELYRIN annual CFF year-on-year change?
- What is ACELYRIN quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ACELYRIN?
- What is ACELYRIN quarterly CFF year-on-year change?
- What is ACELYRIN TTM cash flow from financing activities?
- What is the all time high TTM CFF for ACELYRIN?
- What is ACELYRIN TTM CFF year-on-year change?
What is ACELYRIN annual cash flow from financing activities?
The current annual CFF of SLRN is $568.44 M
What is the all time high annual CFF for ACELYRIN?
ACELYRIN all-time high annual cash flow from financing activities is $568.44 M
What is ACELYRIN annual CFF year-on-year change?
Over the past year, SLRN annual cash flow from financing activities has changed by +$294.17 M (+107.26%)
What is ACELYRIN quarterly cash flow from financing activities?
The current quarterly CFF of SLRN is $1.01 M
What is the all time high quarterly CFF for ACELYRIN?
ACELYRIN all-time high quarterly cash flow from financing activities is $566.47 M
What is ACELYRIN quarterly CFF year-on-year change?
Over the past year, SLRN quarterly cash flow from financing activities has changed by +$1.50 M (+301.60%)
What is ACELYRIN TTM cash flow from financing activities?
The current TTM CFF of SLRN is $6.12 M
What is the all time high TTM CFF for ACELYRIN?
ACELYRIN all-time high TTM cash flow from financing activities is $715.63 M
What is ACELYRIN TTM CFF year-on-year change?
Over the past year, SLRN TTM cash flow from financing activities has changed by -$559.37 M (-98.92%)